# A Study of MF101 in Postmenopausal Women

> **NCT00906308** · PHASE3 · UNKNOWN · sponsor: **Bionovo** · enrollment: 1200 (estimated)

## Conditions studied

- Hot Flushes
- Vasomotor Symptoms

## Interventions

- **DRUG:** MF101 5 g/day
- **DRUG:** Placebo
- **DRUG:** MF101 10 g/day

## Key facts

- **NCT ID:** NCT00906308
- **Lead sponsor:** Bionovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2013-02
- **Final completion:** —
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2012-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906308, "A Study of MF101 in Postmenopausal Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00906308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*